Αποτελέσματα Αναζήτησης
23 Μαρ 2022 · On the basis of immunogenicity data from the primary series and from the booster dose, on December 9, 2021, the FDA authorized a third BNT162b2 dose in persons 16 years of age or older who had...
13 Μαρ 2024 · Several COVID-19 vaccines are available globally. The World Health Organization (WHO) maintains an updated list of vaccine candidates under evaluation and available for administration [1]. This topic will cover vaccines for SARS-CoV-2, with a focus on vaccines available in the United States.
6 Σεπ 2024 · The recommended vaccine and number of 2024–2025 COVID-19 vaccine doses are based on age and vaccination history. COVID-19 vaccination guidance for people who are moderately or severely immunocompromised is detailed in Table 2. Table 1. Routine COVID-19 vaccination schedule, October 31, 2024.
15 Οκτ 2024 · Authorised COVID-19 vaccines. The table below lists the COVID-19 vaccines that are authorised for use in the EU, including originally authorised and adapted vaccines. Adapted vaccines are intended to provide broader protection against different virus variants following initial vaccination.
8 Οκτ 2024 · Currently approved COVID-19 vaccines, including those based on the index virus and the bivalent vaccines, continue to protect against severe disease. For people at a high risk of getting severe COVID-19, a dose of any available vaccine is more beneficial than delaying vaccination.
2 ημέρες πριν · People ages 65 years and older, vaccinated under the routine schedule, are recommended to receive 2 doses of any 2024–2025 COVID-19 vaccine (i.e., Moderna, Novavax, or Pfizer-BioNTech) separated by 6 months (minimum interval 2 months) regardless of vaccination history, with one exception: Unvaccinated people who initiate vaccination with 2024 ...
COVID-19 Vaccine is authorized for adults ages 18 years and older in certain limited situations due to safety considerations. For guidance on respective record review, scheduling and administration of Janssen vaccine see Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendix A. Age indication.
